609 related articles for article (PubMed ID: 17582508)
1. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
2. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
3. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
4. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.
Treuer T; Oruc L; Loza N; El Saidi MA; Kovacs Z; Akkaya C; Gülseren S; Saylan M; Colman SA; Harrison GA
Psychiatr Danub; 2007 Dec; 19(4):282-95. PubMed ID: 18000479
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
Gonzalez-Pinto A; Vieta E; Reed C; Novick D; Barraco A; Aguado J; Haro JM
J Affect Disord; 2011 Jun; 131(1-3):320-9. PubMed ID: 21195486
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
8. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
[TBL] [Abstract][Full Text] [Related]
9. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
[TBL] [Abstract][Full Text] [Related]
10. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
Rosa AR; Cruz N; Franco C; Haro JM; Bertsch J; Reed C; Aarre TF; Sanchez-Moreno J; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
12. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
Novick D; Reed C; Haro JM; Gonzalez-Pinto A; Perrin E; Aguado J; Tohen M
Int Clin Psychopharmacol; 2010 Sep; 25(5):257-63. PubMed ID: 20531011
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
14. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
Bellantuono C; Barraco A; Rossi A; Goetz I
BMC Psychiatry; 2007 Jul; 7():33. PubMed ID: 17640381
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
[TBL] [Abstract][Full Text] [Related]
18. Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
Novick D; Gonzalez-Pinto A; Haro JM; Bertsch J; Reed C; Perrin E; Tohen M;
Pharmacopsychiatry; 2009 Jul; 42(4):145-52. PubMed ID: 19585393
[TBL] [Abstract][Full Text] [Related]
19. [Management of patients with acute manic or mixed episodes and outcome at three months].
Azorin JM; Luquiens A; Aubrun E; Reed C; Gasquet I; Lukasiewicz M
Encephale; 2010 Jun; 36(3):226-35. PubMed ID: 20620265
[TBL] [Abstract][Full Text] [Related]
20. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Yatham LN; Fallu A; Binder CE
Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]